Majluf-Cruz A

Language: Spanish
References: 8
Page: 427-429
PDF size: 97.13 Kb.

Text Extraction

No abstract.

REFERENCES

1. Lobato-Mendizábal E, Majluf-Cruz A. Trombofilia, tromboembolia y el uso de las heparinas no fraccionadas y de bajo peso molecular. Rev Invest Clin. 2000;52:346-65.

2. Majluf-Cruz A, Espinosa-Larrañaga F. Fisiopatología de la trombosis. Gac Med Mex. 2007;143(Supl 1):11-4.

3. Raskob GE, Angchaisuksiri P, Blanco AN, et al. Thrombosis. A major contributor to global disease burden. Arterioscler Thromb Vasc Biol. 2014;34:2363-71.

4. Wendelboe AM, Raskob GE. Global burden of thrombosis: epidemiologic aspects. Circ Res. 2016;118:1340-7.

5. Key NS, Khorana AA, Mackman N, et. al. Thrombosis in cancer: research priorities identified by a National Cancer Institute/National Heart, Lung, and Blood Institute Strategic Working Group. Cancer Res. 2016;76:3671-5.

6. Kourlaba G, Relakis J, Mylonas C, et al. The humanistic and economic burden of venous thromboembolism in cancer patients: a systematic review. Blood Coagul Fibrinolysis. 2015;26:13-31.

7. Disertori M, Franzosi MG, Barlera S, et al. Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trial. BMC Cardiovasc Dis. 2013;13:28.

8. Kourlaba G, Relakis J, Kontodimas S, et al. A systematic review and meta-analysis of the epidemiology and burden of venous thromboembolism among pregnant women. Int J Gynaecol Obstet. 2016;132:4-10.